Effect of teriflunomide versus dimethyl fumarate on cognitive performance in multiple sclerosis patients: real-world data

被引：0
|
作者：
Zohar, D. N. [1 ,2 ]
Achiron, A. [1 ]
机构：
[1] Sheba Med Ctr Hosp, Multiple Sclerosis Ctr, Ramat Gan, Israel
[2] Sheba Med Ctr, Neurol Dept, Ramat Gan, Israel
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1529
引用
收藏
页码：848 / 849
页数：2
相关论文
共 50 条
  • [1] Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
    Norborg, Hilde
    Riise, Trond
    Myhr, Kjell-Morten
    Grytten, Nina
    Wergeland, Stig
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [2] Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
    Norborg, H.
    Riise, T.
    Myhr, K. -M.
    Grytten, N.
    Wergeland, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 712 - 712
  • [3] Real world data on teriflunomide and dimethyl fumarate treatment of multiple sclerosis
    Norborg, H.
    Strauss, P.
    Myhr, K-M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 864 - 864
  • [4] Teriflunomide for multiple sclerosis in real-world setting
    Elkjaer, M. L.
    Molnar, T.
    Illes, Z.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 447 - 453
  • [5] The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
    Wicks P.
    Rasouliyan L.
    Katic B.
    Nafees B.
    Flood E.
    Sasané R.
    BMC Research Notes, 9 (1)
  • [6] Real-world Effectiveness of Dimethyl Fumarate Versus Fingolimod on Cognitive Outcomes
    Hersh, Carrie
    Altincatal, Arman
    de Moor, Carl
    Williams, James R.
    Miller, Catherine
    Koulinska, Irene
    NEUROLOGY, 2021, 96 (15)
  • [7] Real-world patient characteristics, treatment patterns and costs in relapsing multiple sclerosis patients treated with glatiramer acetate, dimethyl fumarate or teriflunomide in Germany
    Ziemssen, Tjalf
    Kurzeja, Anna
    Muresan, Bogdan
    Haas, Jennifer S.
    Alexander, Jessica
    Driessen, Maurice T.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (02) : 93 - 107
  • [8] Effectiveness and safety of dimethyl fumarate treatment in relapsing multiple sclerosis patients: Real-world evidence
    Alroughani R.
    Ahmed S.F.
    Behbehani R.
    Al-Hashel J.
    Neurology and Therapy, 2017, 6 (2) : 189 - 196
  • [9] Effectiveness and safety of dimethyl fumarate treatment in patients with relapsing multiple sclerosis: A real-world evidence
    Alroughani, Raed
    Ahmed, Samar
    Behbehani, Raed
    Al-hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP17 - NP17
  • [10] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
12345